Motreff Pascal, Dauphin Claire, Souteyrand Géraud
CHU Clermont-Ferrand, Service de Cardiologie, Hôpital Gabriel Montpied, 63003 Clermont-Ferrand, France.
Catheter Cardiovasc Interv. 2008 Feb 15;71(3):412-6. doi: 10.1002/ccd.21339.
Percutaneous Patent Foramen Ovale (PFO) closure after paradoxical embolism has become established as a safe, effective and validated procedure. The use of dedicated devices by experienced operators allows for low complication rates and good clinical results in the prevention of paradoxical embolism recurrence. This has led to a widespread use of the technique. However, late complications have been reported after the implantation of different types of devices. We report the first case of cardiac tamponade due to atrial wall erosion, which occurred three months after the implantation of a STARflex device (Nitinol Medical Technologies, Boston, Massachusetts, USA) in a 57 year-old-patient Transoesophageal echocardiographic images and surgical views of the perforation related to the device are presented. This report describes treatment of a late complication that arose following implantation of a STARflex device.
反常栓塞后经皮卵圆孔未闭(PFO)封堵术已成为一种安全、有效且经过验证的手术。经验丰富的操作人员使用专用设备可使并发症发生率较低,并在预防反常栓塞复发方面取得良好的临床效果。这导致该技术得到广泛应用。然而,在植入不同类型的设备后,已有迟发性并发症的报道。我们报告了首例因心房壁侵蚀导致的心包填塞病例,该病例发生在一名57岁患者植入STARflex设备(美国马萨诸塞州波士顿市Nitinol Medical Technologies公司)三个月后。文中展示了与该设备相关穿孔的经食管超声心动图图像和手术视图。本报告描述了STARflex设备植入后出现的迟发性并发症的治疗情况。